Location: Westmont, IL
CIK: 0002050709 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 15, 2026
Total Value: $273M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RLMD | RELMADA THERAPEUTICS INC | 8,474,571 | $58.98M | 21.6% | $3.49 | +15.0% | COM | 75955J402 |
| COGT | COGENT BIOSCIENCES INC | 787,492 | $30.31M | 11.1% | $28.11 | +32.9% | COM | 19240Q201 |
| KALV | KALVISTA PHARMACEUTICALS INC | 985,100 | $19.83M | 7.3% | $13.89 | +11.5% | COM | 483497103 |
| KOD | KODIAK SCIENCES INC | 380,000 | $14.49M | 5.3% | $21.63 | +17.6% | COM | 50015M109 |
| ABVX | ABIVAX SA | 130,000 | $14.48M | 5.3% | $134.85 | — | SPONSORED ADS | 00370M103 |
| EWTX | EDGEWISE THERAPEUTICS INC | 350,000 | $11.03M | 4.0% | $20.07 | +40.4% | COM | 28036F105 |
| NKTR | NEKTAR THERAPEUTICS | 125,000 | $8.994M | 3.3% | $48.33 | 0.0% | COM NEW | 640268306 |
| ANL | ADLAI NORTYE LTD | 1,265,231 | $8.755M | 3.2% | $6.92 | — | SPONSORED ADS | 00704R109 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 3,631,000 | $8.497M | 3.1% | $2.61 | 0.0% | COM | 98943L107 |
| MAZE | MAZE THERAPEUTICS INC | 257,500 | $7.686M | 2.8% | $34.37 | +28.1% | COM | 578784100 |
| SCYX | SCYNEXIS INC | 7,608,695 | $6.976M | 2.6% | $0.73 | 0.0% | COM NEW | 811292200 |
| RLAY | RELAY THERAPEUTICS INC | 672,500 | $6.691M | 2.5% | $8.30 | 0.0% | COM | 75943R102 |
| KALV | KALVISTA PHARMACEUTICALS INC | 315,000 | $6.341M | 2.3% | $13.89 | +11.5% | Call | 483497103 |
| CCCC | C4 THERAPEUTICS INC | 2,250,000 | $5.918M | 2.2% | $2.09 | 0.0% | COM STK | 12529R107 |
| IKT | INHIBIKASE THERAPEUTICS INC | 3,500,000 | $5.88M | 2.2% | $1.59 | +9.0% | COM NEW | 45719W205 |
| PALI | PALISADE BIO INC | 3,000,000 | $5.25M | 1.9% | $1.92 | -7.2% | COM | 696389402 |
| EPRX | EUPRAXIA PHARMACEUTICALS INC | 680,000 | $4.923M | 1.8% | $6.75 | +24.1% | COM | 29842P105 |
| GHRS | GH RESEARCH PLC | 325,000 | $4.569M | 1.7% | $13.69 | +14.8% | ORDINARY SHARES | G3855L106 |
| KPTI | KARYOPHARM THERAPEUTICS INC | 750,000 | $4.178M | 1.5% | — | — | Put | 48576U205 |
| PMN | PROMIS NEUROSCIENCES INC | 324,977 | $4.127M | 1.5% | $12.16 | 0.0% | COM SHS | 74346M505 |
| IDYA | IDEAYA BIOSCIENCES INC | 120,000 | $3.998M | 1.5% | — | — | Put | 45166A102 |
| LPCN | LIPOCINE INC NEW | 450,000 | $3.595M | 1.3% | $3.36 | +173.4% | COM NEW | 53630X203 |
| IDYA | IDEAYA BIOSCIENCES INC | 104,300 | $3.475M | 1.3% | — | — | Call | 45166A102 |
| IVA | INVENTIVA SA | 535,000 | $2.969M | 1.1% | $5.05 | — | ADS | 46124U107 |
| ALXO | ALX ONCOLOGY HLDGS INC | 1,460,000 | $2.927M | 1.1% | $1.77 | 0.0% | COM | 00166B105 |
| CNTX | CONTEXT THERAPEUTICS INC | 1,100,000 | $2.882M | 1.1% | $2.05 | 0.0% | COM | 21077P108 |
| NXTC | NEXTCURE INC | 265,000 | $2.83M | 1.0% | $10.60 | +18.7% | COM NEW | 65343E207 |
| AVBP | ARRIVENT BIOPHARMA INC | 110,000 | $2.538M | 0.9% | — | — | Call | 04272N102 |
| SLGL | SOL-GEL TECHNOLOGIES LTD | 31,000 | $2.456M | 0.9% | $66.40 | 0.0% | SHS NEW | M8694L137 |
| KTTA | PASITHEA THERAPEUTICS CORP | 2,100,000 | $1.558M | 0.6% | $0.88 | -2.3% | COM NEW | 70261F202 |
| RLAY | RELAY THERAPEUTICS INC | 150,000 | $1.492M | 0.5% | $8.30 | 0.0% | Call | 75943R102 |
| TRAW | TRAWS PHARMA INC | 511,714 | $936K | 0.3% | $2.22 | -15.8% | COM NEW | 68232V884 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 400,000 | $936K | 0.3% | $2.61 | 0.0% | Call | 98943L107 |
| TXMD | THERAPEUTICSMD INC | 420,421 | $849K | 0.3% | $2.27 | 0.0% | COM NEW | 88338N206 |
| SPRB | SPRUCE BIOSCIENCES INC | 12,200 | $797K | 0.3% | $107.14 | -30.4% | COM NEW | 85209E208 |
| HOWL | WEREWOLF THERAPEUTICS INC | 563,535 | $469K | 0.2% | $0.64 | 0.0% | COM | 95075A107 |
| NEUP | NEUPHORIA THERAPEUTICS INC | 76,728 | $312K | 0.1% | $4.10 | 0.0% | COM | 64136E102 |